Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction

We examined clinical outcomes with proton pump inhibitors (PPI) use within CYP2C19 genotype groups during clopidogrel treatment following acute myocardial infarction (AMI). 2062 patients were genotyped for CYP2C19*2 and *17 variants in TRIUMPH. 12 month clinical outcomes were analyzed among patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Depta, Jeremiah P., Lenzini, Petra A., Lanfear, David E., Wang, Tracy Y., Spertus, John A., Bach, Richard G., Cresci, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287459/
https://www.ncbi.nlm.nih.gov/pubmed/25001880
http://dx.doi.org/10.1038/tpj.2014.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287459/
https://www.ncbi.nlm.nih.gov/pubmed/25001880
http://dx.doi.org/10.1038/tpj.2014.28

Ejemplares similares